National Ebit from 2010 to 2026
| NHC Stock | USD 169.69 1.36 0.81% |
EBIT | First Reported 1992-03-31 | Previous Quarter 34.2 M | Current Value 55.9 M | Quarterly Volatility 14.1 M |
Check National HealthCare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among National HealthCare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 26.7 M, Interest Expense of 5 M or Total Revenue of 1.6 B, as well as many indicators such as Price To Sales Ratio of 0.64, Dividend Yield of 0.0244 or PTB Ratio of 1.96. National financial statements analysis is a perfect complement when working with National HealthCare Valuation or Volatility modules.
National | Ebit | Build AI portfolio with National Stock |
Analyzing National HealthCare's Ebit over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Ebit has evolved provides context for assessing National HealthCare's current valuation and future prospects.
Latest National HealthCare's Ebit Growth Pattern
Below is the plot of the Ebit of National HealthCare over the last few years. It is National HealthCare's EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in National HealthCare's overall financial position and show how it may be relating to other accounts over time.
| Ebit | 10 Years Trend |
|
Ebit |
| Timeline |
National Ebit Regression Statistics
| Arithmetic Mean | 95,891,890 | |
| Geometric Mean | 86,542,432 | |
| Coefficient Of Variation | 42.33 | |
| Mean Deviation | 29,381,034 | |
| Median | 89,062,000 | |
| Standard Deviation | 40,590,934 | |
| Sample Variance | 1647.6T | |
| Range | 141.9M | |
| R-Value | 0.51 | |
| Mean Square Error | 1308.7T | |
| R-Squared | 0.26 | |
| Significance | 0.04 | |
| Slope | 4,061,889 | |
| Total Sum of Squares | 26362T |
National Ebit History
Other Fundumenentals of National HealthCare
About National HealthCare Financial Statements
National HealthCare stakeholders use historical fundamental indicators, such as National HealthCare's Ebit, to determine how well the company is positioned to perform in the future. Although National HealthCare investors may analyze each financial statement separately, they are all interrelated. For example, changes in National HealthCare's assets and liabilities are reflected in the revenues and expenses on National HealthCare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in National HealthCare. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| EBIT | 161.6 M | 169.7 M | |
| EBITDA | 209.9 M | 220.4 M | |
| Ebt Per Ebit | 1.43 | 0.96 | |
| Ebit Per Revenue | 0.08 | 0.09 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether National HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Healthcare Stock:Check out the analysis of National HealthCare Correlation against competitors. For information on how to trade National Stock refer to our How to Trade National Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Will Health Care Providers & Services sector continue expanding? Could National diversify its offerings? Factors like these will boost the valuation of National HealthCare. Anticipated expansion of National directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every National HealthCare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.08) | Dividend Share 2.5 | Earnings Share 6.48 | Revenue Per Share | Quarterly Revenue Growth 0.125 |
The market value of National HealthCare is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National HealthCare's value that differs from its market value or its book value, called intrinsic value, which is National HealthCare's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because National HealthCare's market value can be influenced by many factors that don't directly affect National HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between National HealthCare's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding National HealthCare should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, National HealthCare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.